Wikidata

(Q63835772)

English

The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial

clinical trial

In more languages

Statements

short name
REGARD-PGx (English)
0 references
title
A Multinational, Multicenter, Single Blood Sampling Exploratory Pharmacogenetic Study of the REGARD (the REbif® vs Glatiramer Acetate in Relapsing MS Disease) Trial (English)
0 references
medical condition
multiple sclerosis
0 references
sclerosis
0 references
start time
February 2010
0 references
end time
November 2010
0 references
number of participants
324
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63835772&oldid=1857471655"